Skip to main content
. 2001 Oct 1;108(7):1071–1077. doi: 10.1172/JCI13297

Figure 2.

Figure 2

Representative FACS dot plot showing human multilineage engraftment in a secondary NOD/SCID recipient of initially transplanted SP fetal liver cells. The bone marrow cells were removed from both femurs and both tibias of a first NOD/SCID mouse transplanted 7 weeks previously with 22,000 SP CD34+CD38– lin– human fetal liver cells, and all of these cells (∼25% of the total bone marrow of that mouse [ref. 48], of which 76% were human) were then transplanted into a second NOD/SCID mouse. The analysis shown is for the bone marrow cells removed from the secondary mouse another 6 weeks later.